Caricamento...
Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain
BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/ https://ncbi.nlm.nih.gov/pubmed/24314138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|